China joins coronavirus vaccine alliance COVAX, with four candidates in late-stage human trials

China had initially declined to join the alliance, missing the global deadline to join in September.

The Associated Press October 09, 2020 09:44:41 IST
China joins coronavirus vaccine alliance COVAX, with four candidates in late-stage human trials

Representational image of vaccines in mass production. Getty/File Image

China, which has four coronavirus vaccine candidates in stage 3 clinical trials, said on Friday that it is joining the COVID-19 vaccine alliance known as COVAX.

The country signed an agreement with GAVI, the co-leader of the alliance, on Thursday, China's Foreign Ministry said in a statement. Initially, China did not agree to join the alliance, missing the global deadline to join in September.

Foreign Ministry spokeswoman Hua Chunying said in a statement that we are taking this concrete step to ensure equitable distribution of vaccines, especially to developing countries, and hope more capable countries will also join and support COVAX.

It is not yet clear the exact terms of the agreement and how China will contribute. The country's leader Xi Jinping previously said that China would make the vaccine a global public good.

The alliance is designed so that richer countries agree to buy into potential vaccines and help finance access for poorer ones. The Trump administration in the US had declined to join the alliance.

Updated Date:

also read

'Should've been an acknowledgement of loss': Opposition reacts to Modi's address on 100 crore COVID-19 jabs
India

'Should've been an acknowledgement of loss': Opposition reacts to Modi's address on 100 crore COVID-19 jabs

The prime minister addressed the nation at 10 am on Friday, saying that the country's vaccine drive was 'science-driven' and treated all people equally

How India defied doomsayers to fight a 'Machiavellian virus with Maoist ability'
India

How India defied doomsayers to fight a 'Machiavellian virus with Maoist ability'

It took the country 281 days to administer 100 crore COVID-19 jabs, placing India at the second place in the total number of vaccinated people

100-crore milestone achieved through made-in-India vaccines, says COVID Task Force chief
India

100-crore milestone achieved through made-in-India vaccines, says COVID Task Force chief

COVID Task Force chief VK Paul, also a Niti Aayog member, said this is an unusual feat and has been achieved in the short period of just nine months of the programme